TrialClinical pharmacology in drug development2022

Safety, Pharmacokinetics, and Pharmacodynamics of Etavopivat (FT-4202), an Allosteric Activator of Pyruvate Kinase-R, in Healthy Adults: A Randomized, Placebo-Controlled, Double-Blind, First-in-Human Phase 1 Trial.

Sanjeev Forsyth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.